Related
Case Study - TreeFrog Therapeutics
TreeFrog Therapeutics (https://treefrog.fr/) is a French biotechnology company specialized in cell therapy. In April 2022, Treefrog announced the opening of a lab in Kobe, Japan, with the aim of establishing strategic alliances with key academic and industrial players in the field of regenerative medicine. Discover the company’s reception in Japan, their encountered challenges, and recommendations to other EU SMEs by reading our Case Study.
Biotech Cluster and SME Mission to Japan
Representatives from 10 EU Biotech companies from 7 EU member states travelled to Osaka and Yokohama to meet Japanese life sciences and pharma companies.
B2B MATCHMAKING EVENT
26
Sep
2022
EU-Japan biotech & pharma partnering conference, Osaka 2022
The EU-Japan Centre for Industrial Cooperation and Osaka Bio Headquarters (Osaka Prefectural Government) have been since 2016 co-organising the EU-Japan Biotech & Pharma Partnering Conference in Osaka, which is a one-to-one business matching event.
Webinar 179: Latest trends in biotechnology research in Japan
21
Sep
2021
The webinar targets start-ups with innovative biotech-related products or services that look for funding from Japanese medical, agricultural, chemical or environmental industries.
Report: Latest trends in biotechnology research in Japan
Japan spends consistently over 3% of its GDP on R&D, of which some 70% come from industry. Concerning biotech-related R&D, more than half is directed towards pharmaceutical and medical goals, but agricultural, industrial and environmental biotech are recently getting more attention in view of a future “bioeconomy” based on “smart cells” and a better integration of biological and digital innovations.
Report: The Japanese Model for a Bioeconomy
To get the access to this report, please click here.
Report: The Biopharmaceuticals Sector in Japan
To get the access to this report, please click here.
Webinar 145: The Biopharmaceuticals sector in Japan
17
Oct
2019
17-10-19 | 10:30 - 11:30 AM CETHow can I access the Japanese market as a novel biopharmaceutical product's owner?Japan includes a hu
Call for Applications for the next Biotech mission to Japan
The Centre is currently inviting EU SMEs and clusters to apply for the next BIOTECH mission to Japan in October.

EU-Japan Centre's News

More
Japan Science and Technology Agency (JST) has pre-announced a call for applications for the 2024…
The Horizon Europe call for EU-Japan collaboration projects (Topic: HORIZON-JU-SNS-2024-STREAM-B-01…
The EU-Japan Centre’s office in Tokyo is regularly publishing "Industry and Policy News”. By…
The European Institute of Innovation & Technology invites you to apply to their one-of-a-kind,…
The EU-Japan Centre is pleased to start a new weekly service by publishing brief summary of the…

Events

More
Online and in Japan
17/06/2024 - 12/07/2024
17-21 June 2024, → mandatory week online (open to SMEs and large companies) 08-12 July 2024, → optional week in Japan (open only to SMEs who have completed the first online week) PROGRAMME…
Japan
01/08/2024 - 31/03/2025
  The organization of the Vulcanus Programme is pending reception of a grant by the EU-Japan Centre for Industrial Cooperation for the Japanese fiscal year 2024-2025: Please note that this call is…
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
Subscribe